Attovia Therapeutics, Inc.
ATTO
IPO
$22.86
-$0.80-3.38%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 39.55% | 41.06% | |||
| Gross Profit | -36.19% | -41.06% | |||
| SG&A Expenses | 9.07% | -24.46% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 33.89% | 23.91% | |||
| Operating Income | -31.19% | -23.91% | |||
| Income Before Tax | -43.27% | -23.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -43.27% | -23.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -43.27% | -23.13% | |||
| EBIT | -31.19% | -23.91% | |||
| EBITDA | -31.34% | -23.51% | |||
| EPS Basic | -31.69% | -12.86% | |||
| Normalized Basic EPS | -31.69% | -12.86% | |||
| EPS Diluted | -31.69% | -12.86% | |||
| Normalized Diluted EPS | -31.69% | -12.86% | |||
| Average Basic Shares Outstanding | 8.80% | 9.10% | |||
| Average Diluted Shares Outstanding | 8.80% | 9.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||